Position in ZTS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$64,206,902
-$4,207,480 QoQ
Shares Held
893,500
+54.4% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#78
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
893,500 | $64,206,902 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
329,065 | $55,460,607 | |
| 3 | VTRS |
Viatris Inc
|
3,423,675 | $54,367,956 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
61,355 | $33,243,974 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,112,894 | $27,388,318 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
147,146 | $16,324,370 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
427,444 | $14,481,798 | |
| 8 | ALKS |
Alkermes plc.
|
222,624 | $11,665,496 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,206,902 | 893,500 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $68,414,382 | 578,753 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $61,274,836 | 487,004 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $60,186,532 | 411,335 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $52,953,598 | 339,555 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $51,824,570 | 314,756 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $90,637,136 | 556,295 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $153,127,507 | 783,742 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $126,768,803 | 731,246 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $128,422,602 | 758,954 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $153,855,635 | 779,529 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $148,392,584 | 852,929 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $144,990,998 | 841,943 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $140,738,331 | 845,580 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $138,666,193 | 946,204 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $116,759,685 | 787,374 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $92,318,333 | 537,078 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $103,455,378 | 548,573 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $164,487,929 | 674,048 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $150,606,429 | 775,762 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $132,228,008 | 709,530 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $104,424,511 | 663,097 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $74,019,542 | 447,248 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $63,964,948 | 386,799 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $54,814,215 | 399,987 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $42,325,675 | 359,637 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||